Meet and network with 70+ emerging companies, established biotech, multi-national nutrition and pharma, alongside notable investors in the industry.
Organized by the publishers of NutraIngredients-USA.com, the number one daily news service for the functional foods and supplements industries, the IPA World Congress + Probiota Americas 2017 in San Francisco, June 7-9, explores the probiotic scientific frontier, its evolution and commercial application in food, supplements and related product areas.
Leading experts present the latest scientific, technical and market insights and business and academia from across the Americas come together to discuss innovation and growth in today’s market.
Oxford Global is proud to present the inaugural Microbiome Discovery and Development Congress on the 12 – 13 June 2017 in Berlin, Germany. This congress will bring together key opinion leaders and senior industry experts in microbiome drug discovery to discuss the latest innovative discovery strategies and technologies, the commercialization of the microbiome and the therapeutic potential. These topics have been compiled as a result of a comprehensive research process undertaken with an expert advisory board with members including Senior Directors and Professors from global pharmaceutical organizations, biotech companies and leading research institutions.
Being part of Microbiome Drug Development Summit gives you the opportunity to get unprecedented access to the latest preclinical, clinical and commercial case studies from the brightest minds in biopharma and academia to turn microbiome discoveries of today into patient therapies of the future.
Microbiome World Congress Americas 2017 will bring together leading pharma and biotechs, academic researcher, and their partners to discuss how to successfully commercialize microbiome-based diagnostics, therapeutics, adjunct therapies and direct-to-consumer services and products.
The Arrowhead Translational Microbiome Conference continues to focus and build on the challenges and hurdles that companies working in the microbiome space will have to recognize and navigate in order to successfully commercialize their products.